Sign in
4

Changes in Ownership

Replimune Group, Inc. Filed Acc 0001104659-24-043256

Chief Medical Officer acquired 26,665 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Xynos Konstantinos Chief Medical Officer 2024-04-01 Grant or award +26,665 139,379 D
Derivatives
Xynos Konstantinos Chief Medical Officer 2024-04-01 Grant or award · Employee Stock Option (right to buy) +80,000 80,000 D
Loading xslF345X05/tm2410652-9_4seq1.xml…